Objective: Japanese physicians' attitudes regarding the health-care needs of young adult childhood cancer survivors (CCSs) are not well described. Thus, we examined the self-reported preferences and knowledge of pediatric oncologists and surgeons. Methods: A mailed survey was sent to 858 physician members of the Japanese Society of Pediatric Oncology. We compared the responses of pediatric oncologists and pediatric surgeons. Results: The pediatric oncologists' response rate was 56% (300 out of 533) and that of pediatric surgeons 32% (105 out of 325). The median age of respondents was 46 and 48 years, respectively; 79 and 84% were men. When comfort levels in caring for CCSs were described (i.e. 1 ¼ very uncomfortable; 7 ¼ very comfortable), the mean levels were 4.4 and 3.8 with CCSs 21 years, 3.6 and 3.6 with 21 years , CCSs 30 years, and 2.8 and 3.3 with CCSs . 30 years, respectively. In clinical vignette questions, 62% of the pediatric oncologists and 43% of the surgeons answered three or more questions appropriately. Pediatric surgeons reported significantly lower familiarity with long-term follow-up guidelines than pediatric oncologists. Most pediatric oncologists and many surgeons conducted truth-telling of cancer diagnosis to adult CCSs now. They thought that the most important issues are an original long-term follow-up guideline suitable for the Japanese situation and collaborations with adult-based general physicians. Conclusions: Many Japanese pediatric oncologists are uncomfortable with caring for survivors as they age and have suboptimal knowledge regarding late effects. The change in truth-telling situation and preference for collaboration with adult-based physicians was demonstrated also in Japan.
INTRODUCTION
As a result of treatment advances, almost 80% of children diagnosed with cancer become long-term survivors (1) . In Japan, there are over 50 000 childhood cancer survivors (CCSs), or approximately 1 in 700 adults between the ages of 20 and 39 years has cancer experience (2) . Many of these survivors face significant life-long health risks (3) and early mortality (4) . Treatment-related late effects are often clinically insidious for years or decades after the completion of cancer treatment (5, 6) . Promotion of healthy lifestyle behaviors and provision of regular risk-based medical care and surveillance may modify the evolution of these late effects. However, many CCSs engage in risky health behaviors and do not receive adequate risk-based medical care (7) .
In 2007, the members of the International BerlinFrankfurt-Munster (I-BFM) Early and Late Toxicity Educational Committee (ELTEC) published the Erice statement to summarize what the group considers essential for the care of survivors (8) . Included in the Erice statement was the following point: 'when the survivor enters adulthood, he/she should be referred to an appropriate health care provider who coordinates long-term care' (8) . Despite these recommendations, many reports suggest that effective transitions from the pediatric to the adult-focused health-care system are difficult (9) (10) (11) .
One well-described barrier to risk-based long-term healthcare is that CCSs themselves are not well informed regarding their previous therapies or their potential risks for late effects (12, 13) . In the past study, CCSs in Japan did not always know the precise diagnosis of cancer itself (14) . We recently reported that the previous treatment hospitals (where CCSs were treated for their cancer) were the most commonly visited medical facilities for the CCS group (74% for females and 64% for males) and more than half of CCSs preferred to continue visiting the previous treatment hospitals with full satisfaction in Japan (15) . Recently, Henderson et al. (16) published a comprehensive report on physicians' attitudes and knowledge regarding the health-care needs of CCSs in the USA. On the other hand, there is no information in Japan regarding whether the pediatric oncologists in the previous treatment hospitals are comfortable with these adult-aged CCSs and have knowledge of the published guidelines or recommendations for late-effect surveillance (17, 18) . In addition, many CCSs have received long-term follow-up not only with pediatric oncologists but also with pediatric surgeons in Japan. To further understand physician attitudes and knowledge regarding the care of CCSs as they transition into adulthood in Japan, we conducted a comparative survey of pediatric oncologists and pediatric surgeons who belonged to the Japanese Society of Pediatric Oncology (JSPO).
PATIENTS AND METHODS

PARTICIPANTS
The approval of both St Luke's International Hospital review board and the director board in JSPO was obtained before initiation of this study. Candidate participants were selected from the 2010 JSPO Membership Directory. From the available directory, 1381 potential survey members with sufficient addresses for survey mailings were identified. Of those, we identified 1022 members specialized in pediatric hematology/oncology or pediatric surgical oncology.
SURVEY MAILINGS
A self-addressed survey was mailed to the 1022 eligible members. Through the initial mailing, 16 physicians were eliminated because of incorrect mailing addresses or because physicians were no longer clinically active, yielding a final sample of 1006 survey members. A second mailing was sent to all potential participants 4 weeks after the initial mailing.
SURVEY METHOD
The survey instrument was developed originally. Survey content and format was based on a previous study (16) regarding physician preferences and knowledge. The survey included 14 questions and used both quantitative (i.e. closed-ended questions) and qualitative (i.e. open-ended questions that asked for short responses) items (Supplementary data 1). The survey sought demographic information about participant's age, sex, practice environment, years since completion of formal training, estimated number of patients with cancer and cancer survivors seen per week in clinical practice, and information regarding prior learning with regard to childhood cancer survivorship. The definition of CCS was a patient who was at least 5 years from the completion of cancer therapy and was malignancy free.
Quantitative survey items queried participants regarding whether their practices were affiliated with a long-term follow-up program for cancer survivors and if it was routine practice to eventually refer their long-term survivors to other physicians. By using a seven-point Likert scale, physicians were asked about their comfort with caring for survivors at varying ages and were asked about their familiarity with the available monitoring guidelines for adolescent and young adult cancer survivors. Quantitative questions queried selfreported attitudes toward caring for long-term CCSs, referral pattern practices for their CCSs and their opinion of the best trajectory of care for CCSs.
The survey included a vignette of a 25-year-old woman treated at age 1 year for acute lymphoblastic leukemia whose treatment included prophylactic cranial radiation (24 Gy) and anthracycline and cyclophosphamide chemotherapy in Supplementary data 2. Three follow-up questions sought physicians' self-reports of the knowledge of health risks caused by pediatric cancers and the physicians' understanding of appropriate surveillance for these health risks on the basis of Japanese leukemia/lymphoma study group (JPLSG)'s recommendation (19) .
Finally, participants were asked to give a free description whether they had anything else to add about their
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Physician preferences for cancer survivors' care Continued experiences with CCSs or the survey itself. After conducting a pilot testing with five pediatric oncologists, revisions were made. The survey questions were mailed with a cover letter to explain the purpose of the study and how to return the survey and introduce the original article (16) . The survey was designed to be sealed within an envelope and mailed back to the study investigator (Y.I.) anonymously.
STATISTICAL ANALYSES
All survey data were coded and entered into a database by using standard SPSS statistical software, ver. 19.0 (IBM Japan Co. Ltd, Tokyo, Japan). Descriptive statistics reported included the following: proportions, means and standard deviations, or medians and ranges. For between-group comparisons of continuous or ordinal variables, t-tests or non-parametric Wilcoxon's rank-sum tests were used as appropriate. For comparisons of categorical variables, x 2 tests were used. As for cross-table comparisons, we used adjusted standardized residuals to evaluate the difference between the observed and expected values; the columns which give more than 1.96 of the adjusted standardized residual were considered as significant.
RESULTS
The two survey mailings were completed between October 2010 and January 2011. Four hundred fifty surveys returned; we excluded 45 sheets from non-pediatricians or nonpediatric surgeons. Physicians were asked to choose one of four responses that best summarized their current attitudes toward caring for long-term CCSs. As depicted in Table 2 , 38% of the pediatric oncologists and 32% of the pediatric surgeons preferred following long-term CCSs as long as possible. There was no statistically significant difference between pediatric oncologists and pediatric surgeons.
As the optimal care of long-term CCSs, 51% of the pediatric oncologists and 42% of the pediatric surgeons answered that a CCS stays in their care until age 21 and then is referred. More pediatric surgeons answered that a CCS stays in their care anywhere between 2 and 5 years after the completion of therapy and then is referred regardless of his/her age. 
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REFERRAL PREFERENCES
Respondents were asked to report if it was their practice to eventually refer their long-term cancer survivors to other physicians and 31% of respondents answered yes. One-third (34%) of these respondents reported referring long-term survivors to a long-term follow-up program, 23% reported referring them to a primary care physician, 29% responded that they referred them to adult oncologists and 13% reported referring them to some other physician or healthcare provider.
COMFORT LEVELS OF CARING FOR CCSS
Three survey items queried participants' comfort levels with caring for pediatric cancer survivors within three different age groups (Fig. 1 ). Respondents were asked to report their comfort levels on a seven-point Likert scale. A score of 1 was associated with very uncomfortable; a score of 7 was associated with being very comfortable. Both pediatric oncologists and pediatric surgeons reported being most comfortable with caring for survivors who were 21 years of age or younger (mean + SD, 4.4 + 1.3 and 3.8 + 1.4 level, respectively), being less comfortable with survivors older than 21 years and ,30 years (3.6 + 1.4 and 3.6 + 1.4 level, respectively) and being most uncomfortable caring for survivors 30 years or older (2.8 + 1.5 and 3.3 + 1.6 level, respectively). While pediatric oncologists became less comfortable with survivors as they aged out of the pediatric age range, pediatric surgeons' comfort levels remained relatively consistent throughout all age groups.
KNOWLEDGE OF RECOMMENDATIONS FOR LATE EFFECTS
Participants' knowledge of the current JPLSG recommendations for surveillance of late effects was examined through a vignette that described a 25-year-old woman treated at age 1 year for ALL with 24 Gy cranial radiation and anthracyclines (cumulative dose: 180 mg/m 2 ). Respondents were asked about the follow-up frequency and method, hepatitis C infection and late effects of cranial radiation (Supplementary data 2). On the basis of the JPLSG recommendations, 78% of the pediatric oncologists and 70% of the pediatric surgeons appropriately recommended the follow-up frequency and method (not significant); however, 53% of the pediatric oncologists and 38% of the pediatric surgeons appropriately recommended hepatitis C infection treatment; this difference was significant. Lastly, 92/49% of the pediatric oncologists and 77/36% of the pediatric surgeons appropriately answered the questions related with the late effects of cranial radiation (statistically significant, respectively). Overall, only 47% of the respondents (62% of the pediatric oncologists and 43% of the pediatric surgeons) answered three or more questions appropriately.
FAMILIARITY WITH LONG-TERM FOLLOW-UP GUIDELINES
Participants were queried about their familiarity with the available monitoring guidelines for adolescent and young adult cancer survivors by using a seven-point Likert scale. The definition of familiarity was left to the discretion of the individual respondent. A score of 1 meant a respondent was very unfamiliar, a score of 4 meant they were somewhat familiar and a score of 7 reflected that a respondent was very familiar. Overall, surveyed pediatric oncologists were significantly more familiar with the available guidelines than pediatric surgeons; the mean score (+SD) was 2.8 (+1.4) for pediatric oncologists and 1.5 (+1.4) for pediatric surgeons (P , 0.001).
THE PROPORTION OF TRUTH-TELLING OF CANCER DIAGNOSIS IN ADULT CCSS
Seventy percent of the pediatric oncologists and 62% of the pediatric surgeons in this study reported that the proportion of truth-telling of cancer was 80 -100% (Fig. 2 ). There was a statistical significant difference in distribution between pediatric oncologists and pediatric surgeons (P , 0.001).
LEVEL OF INTEREST IN COLLABORATIONS WITH ADULT-BASED CLINICIANS TO CARE FOR CCS
Participants were queried about their interest in collaborations with adult-based clinicians to care for CCSs by using a seven-point Likert scale. Overall, both pediatric oncologists and pediatric surgeons were much interested in collaborations with adult physicians, as the mean score (+SD) was 3.1 (+1.6) for pediatric oncologists and 3.0 (+1.5) for pediatric surgeons.
IMPORTANT ISSUES FOR A LONG-TERM FOLLOW-UP OF ADULT CCSS
The most important issues for long-term follow-up for adult CCSs cited by both pediatric oncologists and pediatric surgeons were an original long-term follow-up guideline suitable for the Japanese situation and a passport (individualized clinical records) to share information (Table 3 ). There was no significant difference in distribution between pediatric oncologists and pediatric surgeons with regard to the most important issues. However, as for important issues for collaboration with adult-based general physicians, both pediatric oncologists and surgeons think that it is of prime importance to have enough knowledge about late effects. More pediatric oncologists than pediatric surgeons demanded sympathy with CCSs and/or their parents, and the ability to introduce organ-specific specialists.
DISCUSSION
We found that pediatric oncologists in Japan were increasingly uncomfortable with caring for adult survivors as they age, and the preference and knowledge with regard to longterm follow-up care of young-adult CCSs were different between pediatric oncologists and surgeons in Japan. To our knowledge, our survey is the first large study in Japan that examines physician attitudes toward and knowledge of riskbased healthcare, including surveillance of late effects of CCSs.
The results of our study are consistent with Henderson et al.'s study of US pediatric oncologists (16) . First, as the age of CCSs increases, pediatric oncologist-reported comfort levels in caring for them decrease. However, in contrast to the Henderson study, more physicians report that they prefer to observe their CCSs for as long as possible when compared with US physicians (16) . Japanese physicians have had profound attachment with their patients, which is observed in doctor -patient relationships in chronically or severely ill children as reported also in western countries (20 -22) . In this study, many Japanese physicians had felt uncomfortable to follow adult CCSs by themselves. Systematic efforts should be made after cancer treatment not only to empower the CCSs/families by making available age-appropriate 
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Physician preferences for cancer survivors' care information but also to provide adult-based physicians the necessary information (8) . These efforts will be especially important in dealing with the sustainable transition from the pediatric to the adult-focused health-care system. A specific program will be needed to facilitate these transitions (10, 23, 24) . Secondly, the survey results suggest that many pediatric oncologists in Japan are not familiar with available longterm follow-up guidelines compared with US pediatric oncologists (16) , mainly because there is no available longterm follow-up guideline for CCSs in Japanese today. Recently, we formulated the Japanese translated version of COG long-term follow-up guidelines in JPLSG homepage (http://www.jplsg.jp/) (19) . Only 62% of the pediatric oncologists and 43% of the pediatric surgeons answered three or more of our four vignette-based questions regarding late effects on the basis of available JPLSG recommendations (19) .
To achieve effective follow-up for CCSs, truth-telling is an indispensable process for CCSs (12, 13) . In 2007, Parsons et al. (14) reported that US physicians had a consistent pattern of telling children (65% always told the child; ,1% rarely or never told), while Japanese physicians had greater variability in their patterns of telling (with only 9.5% always telling and 34.5% rarely or never telling). During these 10 years, the situation around truth-telling to children with cancer has been dramatically changed in Japan. Our study demonstrated that most pediatric oncologists conduct truthtelling of cancer diagnosis at least to adult CCSs now, and there are no barriers to facilitating effective follow-up.
The most important issues for long-term follow-up for adult CCSs cited by both pediatric oncologists and pediatric surgeons in this survey were an original long-term follow-up guideline suitable for the Japanese situation and a follow-up passport to share information. The long-term followup committee of JPLSG has been developing new original guidelines and a long-term follow-up diary now.
It is very interesting that most pediatric oncologists and pediatric surgeons demand not only enough knowledge about late effects of CCSs but also 'sympathy' with CCSs and/or their parents from adult-based general physicians for the purpose of collaboration. There were a lot of opinions to list 'sympathetic ability' as an indispensable nature to succeed transition though semi-structured interviews of the pediatricians in long-term follow-up (25) . To our knowledge, many CCSs who were once introduced to an adult department returned to the pediatric department again because of the reasons: 'an adult-based physician is cold' or 'he/she doesn't listen to my story enough', and many CCSs had a sense of hesitation in consulting the adult-based physician.
This study has important strengths. First, this study is based on a national study including not only pediatric oncologists but also pediatric surgeons involved in pediatric oncology practice in JSPO. We can compare between pediatric oncologists and pediatric surgeons with regard to their preference and knowledge about adult CCSs. Secondly, this study revealed for the first time the change in the truthtelling situation in Japan and the preference for collaboration with adult-based physicians to care for adult CCSs.
There are, however, some limitations to our study. First, the response rates were not satisfactory especially for pediatric surgeons. These results may be subject to a response bias (i.e. those with a stronger interest in the topic may have been more likely to have responded to our survey). Conversely, there was no statistically significant difference in the gender or geographic location of responders compared with nonresponders, age and time in practice of non-responders by the available JSPO member's information. Secondly, the . Given the limitations, it is important that additional studies be undertaken to explore physician attitudes and knowledge outside the cancer center-based pediatric oncology specialty to include physicians in adult oncology as well as in primary care, including pediatrics, internal medicine and family medicine. Lastly, it must be highlighted that the current JPLSG recommendations, on which our clinical vignette questions were created, are based on limited data and, in many cases, expert opinion.
In conclusion, our study suggests that pediatric oncologists are increasingly uncomfortable with caring for survivors as they age and have suboptimal knowledge regarding the current recommendations for late effects. Preference and knowledge with regard to long-term follow-up care of young-adult CCSs are different between pediatric oncologists and pediatric surgeons in Japan. Findings from this study should provide a foundation for additional research and possible targeted interventions that hope to improve physician knowledge.
